At yesterday’s close, the MedMen Enterprises (OTCQX: MMNFF) stock price was up33.93% to $1.29. In contrast to the Average Monthly Volume of 15.10M, the stock price ranged from $1.08to $1.47 during the day, with a volume of 42.71M. When we analyze stocks’ past performance, their 1-week performance was 374.26%, while their 3-month performance was 654.39%.
MMNFF Business Profile
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
MedMen Enterprises (OTCQX: MMNFF) is one of the largest cannabis retailers in the U.S., with branches in Los Angeles, Las Vegas, Chicago, and New York. Through its premium retail stores, proprietary delivery service, curbside and in-store pickup, and MedMen-owned brands, [statemade], LuxLyte, and MedMen Red, MedMen offers a robust selection of high-quality products.
Most Recent Developments
- February 09, 2021, MedMen Enterprises Inc. (OTCQX: MMNFF) announced to the public that it had engaged Moelis & Company LLC to provide the company with more financial stability and shareholder value.
“We are delighted to work with Moelis as our financial advisor as a testament to the professionalization of the cannabis industry, and the quality of our efforts will serve our customers and strengthen our Company for our employees and shareholders,” noted Tom Lynch, Chairman, and CEO of MedMen.
- February 04, 2021, MedMen Enterprises (OTCQX: MMNFF) revealed that on Tuesday, February 16, 2021, after market close, it will release its financial results for the second quarter of fiscal 2021 ended December 26, 2020.
Experts consider that the pharmaceutical industry is entering a golden age. The development of medical science has enabled previously impossible methods of treating and preventing disease. Investing in stocks of this Industry may offer investors a lucrative opportunity in this period.